BJDX — Bluejay Diagnostics Share News
0.000.00%
Last trade - 00:00Brief: Bluejay Diagnostics Appoints Kenneth Fisher As Chief Financial Officer
Brief: Bluejay Diagnostics- Testing Program Underway For Lead Product Candidate, Symphony Il-6 Test, In Support Of FDA Marketing Application, Planned For Q3 2022
Brief: Bluejay Diagnostics Announces Pre-Submission Filing Package For The Symphony IL-6 Test Is With The FDA
Brief: Bluejay Diagnostics, Inc. Completes 90 Subjects In Multicenter Clinical Study Addressing Rapid Il-6 Test For Covid-19 Patients In Critical Care
Brief: Bluejay Diagnostics Reports Q3 Loss Per Share Of $0.11
Brief: Bluejay Diagnostics Prices Upsized $21.6 Million Initial Public Offering
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:59 AM